- Home
- RNXT vs CLDI Comparison
RNXT vs CLDI Comparison
Compare RNXT & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- CLDI
- Stock Information
- Founded
- RNXT 2012
- CLDI 2014
- Country
- RNXT United States
- CLDI United States
- Employees
- RNXT N/A
- CLDI N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RNXT Health Care
- CLDI Health Care
- Exchange
- RNXT Nasdaq
- CLDI Nasdaq
- Market Cap
- RNXT 21.6M
- CLDI 18.1M
- IPO Year
- RNXT 2021
- CLDI N/A
- Fundamental
- Price
- RNXT $1.08
- CLDI $2.13
- Analyst Decision
- RNXT Strong Buy
- CLDI Strong Buy
- Analyst Count
- RNXT 3
- CLDI 3
- Target Price
- RNXT $6.13
- CLDI $16.67
- AVG Volume (30 Days)
- RNXT 29.1K
- CLDI 3.1M
- Earning Date
- RNXT 11-13-2024
- CLDI 11-12-2024
- Dividend Yield
- RNXT N/A
- CLDI N/A
- EPS Growth
- RNXT N/A
- CLDI N/A
- EPS
- RNXT N/A
- CLDI N/A
- Revenue
- RNXT N/A
- CLDI N/A
- Revenue This Year
- RNXT N/A
- CLDI N/A
- Revenue Next Year
- RNXT N/A
- CLDI N/A
- P/E Ratio
- RNXT N/A
- CLDI N/A
- Revenue Growth
- RNXT N/A
- CLDI N/A
- 52 Week Low
- RNXT $0.53
- CLDI $0.73
- 52 Week High
- RNXT $2.35
- CLDI $26.30
- Technical
- Relative Strength Index (RSI)
- RNXT 57.50
- CLDI 66.00
- Support Level
- RNXT $1.04
- CLDI $1.40
- Resistance Level
- RNXT $1.05
- CLDI $3.89
- Average True Range (ATR)
- RNXT 0.07
- CLDI 0.36
- MACD
- RNXT 0.01
- CLDI 0.17
- Stochastic Oscillator
- RNXT 71.43
- CLDI 52.86
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.